Additives in parenteral formulations MCQs With Answer

Additives in parenteral formulations are essential excipients that ensure safety, stability and efficacy of injectable medicines. For B. Pharm students, understanding the roles of tonicity agents, buffers, preservatives, antioxidants, chelating agents, surfactants, solubilizers and co-solvents is critical for formulation design and regulatory compliance. Key considerations include compatibility with active pharmaceutical ingredients (APIs), effects on pH and osmolarity, prevention of oxidation and aggregation, and interactions with packaging materials. Knowledge of sterilization methods, particulate control, and preservative selection for single- versus multi-dose products is also important. This set emphasizes practical examples, typical concentrations and stability implications. Now let’s test your knowledge with 30 MCQs on this topic.

Q1. Which additive is primarily used to adjust osmolarity and achieve isotonicity in parenteral formulations?

  • Sodium chloride
  • Sodium metabisulfite
  • Polysorbate 80
  • EDTA

Correct Answer: Sodium chloride

Q2. Which class of additives is used to prevent oxidative degradation of susceptible APIs?

  • Antioxidants
  • Preservatives
  • Buffers
  • Surfactants

Correct Answer: Antioxidants

Q3. Which preservative is commonly avoided in neonates due to toxicity concerns?

  • Benzyl alcohol
  • Phenol
  • m-Cresol
  • Chlorobutanol

Correct Answer: Benzyl alcohol

Q4. EDTA in parenteral formulations acts primarily as a:

  • Chelating agent
  • Tonicity agent
  • Solubilizer
  • Preservative

Correct Answer: Chelating agent

Q5. Which surfactant is frequently used to prevent protein adsorption and aggregation in injectables?

  • Polysorbate 80
  • Sodium chloride
  • Sodium metabisulfite
  • Propylene glycol

Correct Answer: Polysorbate 80

Q6. Which buffer system is commonly used to maintain pH around physiological pH in parenterals?

  • Phosphate buffer
  • Acetate buffer
  • Sulfate buffer
  • Borate buffer

Correct Answer: Phosphate buffer

Q7. Which additive improves solubility of poorly water-soluble drugs by inclusion complex formation?

  • Cyclodextrin
  • EDTA
  • Phenol
  • Sodium chloride

Correct Answer: Cyclodextrin

Q8. Terminal sterilization by moist heat can degrade certain additives; which additive class is most at risk?

  • Protein stabilizers and some antioxidants
  • Inorganic salts like NaCl
  • Cyclodextrins
  • Silicone oil

Correct Answer: Protein stabilizers and some antioxidants

Q9. Which co-solvent is commonly used to increase solubility but can cause hemolysis at high concentrations?

  • Propylene glycol
  • Sucrose
  • Polysorbate 20
  • EDTA

Correct Answer: Propylene glycol

Q10. What is the main function of preservatives in multi-dose parenteral formulations?

  • Prevent microbial growth after vial entry
  • Adjust pH
  • Enhance solubility of API
  • Control osmolarity

Correct Answer: Prevent microbial growth after vial entry

Q11. Which preservative is frequently used in insulin formulations?

  • m-Cresol
  • EDTA
  • Ascorbic acid
  • Sodium chloride

Correct Answer: m-Cresol

Q12. Phenol acts in parenterals primarily as a:

  • Preservative with bactericidal activity
  • Buffer component
  • Chelating agent
  • Solubilizer

Correct Answer: Preservative with bactericidal activity

Q13. Which test monitors particulate contamination in parenteral products?

  • Particulate matter test (light obscuration)
  • Sterility test
  • Pyrogen test
  • Assay by HPLC

Correct Answer: Particulate matter test (light obscuration)

Q14. Which antioxidant works by donating hydrogen atoms to free radicals and is sometimes used in parenterals?

  • Ascorbic acid (vitamin C)
  • Polysorbate 80
  • Benzalkonium chloride
  • Sodium chloride

Correct Answer: Ascorbic acid (vitamin C)

Q15. Sodium metabisulfite in parenteral formulations is used as an:

  • Antioxidant/reducing agent
  • Preservative
  • Buffering agent
  • Tonicity agent

Correct Answer: Antioxidant/reducing agent

Q16. Which additive can leach from rubber stoppers and affect drug stability?

  • Butylated compounds or plasticizers
  • Sodium chloride
  • Cyclodextrin
  • EDTA

Correct Answer: Butylated compounds or plasticizers

Q17. For sterile filtration of solutions containing proteins, which filter pore size is commonly used to remove bacteria while minimizing protein loss?

  • 0.22 µm
  • 0.45 µm
  • 1.2 µm
  • 5.0 µm

Correct Answer: 0.22 µm

Q18. Which additive class can stabilize proteins by preferentially excluding solvent and increasing native conformation?

  • Polyols (e.g., sucrose, trehalose)
  • Preservatives like phenol
  • Antioxidants like BHT
  • Chelating agents like EDTA

Correct Answer: Polyols (e.g., sucrose, trehalose)

Q19. Which preservative is a quaternary ammonium compound sometimes used in ophthalmic but rarely in parenterals due to toxicity?

  • Benzalkonium chloride
  • m-Cresol
  • Chlorobutanol
  • Phenol

Correct Answer: Benzalkonium chloride

Q20. Which factor often accelerates oxidation of APIs in parenteral formulations?

  • Presence of transition metal ions
  • Use of isotonic sodium chloride
  • Low buffer capacity
  • High surfactant concentration

Correct Answer: Presence of transition metal ions

Q21. Polysorbates can degrade and generate which harmful species affecting proteins?

  • Peroxides and free radicals
  • EDTA complexes
  • Inorganic salts
  • Isotonic sugars

Correct Answer: Peroxides and free radicals

Q22. Chlorobutanol is used in parenterals primarily as a:

  • Preservative and mild local anesthetic
  • Buffering agent
  • Chelator
  • Solubilizer

Correct Answer: Preservative and mild local anesthetic

Q23. Which excipient can protect against metal-catalyzed oxidation by complexing trace metals?

  • EDTA
  • Polysorbate 80
  • Cyclodextrin
  • Propylene glycol

Correct Answer: EDTA

Q24. For parenteral pH adjustment, which acid/base pair is commonly used?

  • Hydrochloric acid and sodium hydroxide
  • Acetic acid and ammonium hydroxide
  • Citric acid and sodium citrate
  • Boric acid and sodium borate

Correct Answer: Hydrochloric acid and sodium hydroxide

Q25. Which additive is used to reduce surface tension and help solubilize lipophilic drugs?

  • Surfactants (e.g., polysorbates)
  • Buffers
  • Preservatives
  • Chelating agents

Correct Answer: Surfactants (e.g., polysorbates)

Q26. Which concern is critical when selecting a preservative for a protein therapeutic?

  • Preservative-induced protein aggregation or denaturation
  • Effect on osmolarity only
  • Ability to chelate metals
  • Enhancement of viscosity

Correct Answer: Preservative-induced protein aggregation or denaturation

Q27. Which additive class is used to buffer solutions and resist pH changes upon dilution or addition?

  • Buffers
  • Antioxidants
  • Surfactants
  • Co-solvents

Correct Answer: Buffers

Q28. Which container–closure interaction can lead to loss of drug potency via adsorption?

  • Adsorption of drug to glass or rubber surfaces
  • Increase in isotonicity
  • Change in buffer capacity
  • Formation of EDTA complexes

Correct Answer: Adsorption of drug to glass or rubber surfaces

Q29. Which regulatory reference provides standards for additives and quality tests in parenteral formulations?

  • USP–NF (United States Pharmacopeia–National Formulary)
  • ICH Q9 only
  • ISO 9001 exclusively
  • CFR Title 21 Part 11 exclusively

Correct Answer: USP–NF (United States Pharmacopeia–National Formulary)

Q30. Which method is preferred to sterilize heat-sensitive parenteral solutions without terminal sterilization?

  • Aseptic processing with sterile filtration (0.22 µm)
  • Autoclaving at 121°C for 15 minutes
  • Dry heat sterilization at 160°C
  • Gamma irradiation of aqueous solution

Correct Answer: Aseptic processing with sterile filtration (0.22 µm)

Leave a Comment